| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.12 | 0.5 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.5 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |